SCANTOX Trademark
Trademark Overview
On Monday, September 11, 2023, a trademark application was filed for SCANTOX with the United States Patent and Trademark Office. The USPTO has given the SCANTOX trademark a serial number of 79388249. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, December 9, 2024. This trademark is owned by Scantox A/S. The SCANTOX trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services, namely, blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; veterinary services
Scientific and technological services and research and design related hereto, namely, development of blood tests for clinical analysis and pathology, Scientific research in the nature of pharmaceutical dosage formulation analysis, Scientific and technological services, namely, scientific research, analysis, testing in the field of biology, and testing of pharmaceuticals for safety purposes, and quality control for others
General Information
| Serial Number | 79388249 |
| Word Mark | SCANTOX |
| Filing Date | Monday, September 11, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, December 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2024 |
Trademark Statements
| Goods and Services | Medical services, namely, blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; veterinary services |
| Goods and Services | Scientific and technological services and research and design related hereto, namely, development of blood tests for clinical analysis and pathology, Scientific research in the nature of pharmaceutical dosage formulation analysis, Scientific and technological services, namely, scientific research, analysis, testing in the field of biology, and testing of pharmaceuticals for safety purposes, and quality control for others |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 2, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Scantox A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK |
Trademark Events
| Event Date | Event Description |
| Thursday, February 1, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, February 2, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 6, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, May 7, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, May 15, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, May 25, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, May 25, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, May 16, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, June 17, 2024 | REFUSAL PROCESSED BY IB |
| Saturday, November 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, November 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, November 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 4, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, December 4, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 4, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 4, 2024 | EXAMINER'S AMENDMENT ENTERED |
